Mizuho Medy Co.,Ltd.

TSE:4595.T

1557 (JPY) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q4
Revenue 1,9262,7422,999.3273,414.782,183.8632,391.7654,300.3615,967.7133,125.4664,188.292,550.7144,057.6483,903.7562,374.1521,710.756828.873611.081,052.5942,299.6711,280.4591,031.0311,815.7492,152.6631,176.923943.1872,152.3092,058.4541,036.452897.8241,631.2462,019.423789.112689.081,464.5741,468.088
Cost of Revenue 604786829.507763.634635.698686.8481,038.6961,059.498566.79816.773717.392730.423919.616866.775441.505362.799274.332365.88755.593386.016362.674583.317687.74445.597320.011645.227657.992443.407304.526558.931725.677355.417207.374483.166520.73
Gross Profit 1,3221,9562,169.822,651.1461,548.1651,704.9173,261.6654,908.2152,558.6763,371.5171,833.3223,327.2252,984.141,507.3771,269.251466.074336.748686.7141,544.078894.443668.3571,232.4321,464.923731.326623.1761,507.0821,400.462593.045593.2981,072.3151,293.746433.695481.706981.408947.358
Gross Profit Ratio 0.6860.7130.7230.7760.7090.7130.7580.8220.8190.8050.7190.820.7640.6350.7420.5620.5510.6520.6710.6990.6480.6790.6810.6210.6610.70.680.5720.6610.6570.6410.550.6990.670.645
Reseach & Development Expenses 190164193159163.466154185147152121161137135159509000461000460000386000356000306
General & Administrative Expenses 0011100010300098000920009000084000780007100065
Selling & Marketing Expenses 00503.148000565.6730002240003840001,0530001,0440009910001,004000727
SG&A 541539614.148606.253508.94523.253668.673640.968574.066507.161642.834646.044602.148470.53947576464688446798616850441634596955466581581784460517530792327
Other Expenses 220.3540.5722.133.7731.8181.5760.8432.9740.154-1.6010.1991.9220.1060.2040.3110.210.2090.2410.5130.587-9.9310.2060.3660.486-0.120.3110.8320.315-3.670.3130.8340.3262.328
Operating Expenses 731703807.148765.253672.406677.253853.668787.968726.066628.161803.829783.044737.148629.539613.812575.999464.248688.503963.322798.575616.077850.252920.753633.488596.077955.47861.979580.913581.43784.355495.603516.879530.539792.185343.32
Operating Income 5911,2531,362.6721,885.893875.7581,027.6632,407.9914,120.2481,832.612,743.3551,029.4872,544.1812,246.992877.837655.436-109.926-127.5-1.788580.7595.86952.279382.179544.16497.83927.099551.611538.47912.13311.869287.958472.232-83.183-48.832189.221305.569
Operating Income Ratio 0.3070.4570.4540.5520.4010.430.560.690.5860.6550.4040.6270.5760.370.383-0.133-0.209-0.0020.2530.0750.0510.210.2530.0830.0290.2560.2620.0120.0130.1770.234-0.105-0.0710.1290.208
Total Other Income Expenses Net 118119-65.91456.687126.85722.856-110.84873.14-0.6685.0580.12430.58579.65715.652-0.209-0.4420.112-0.51159.004-0.3131.085-0.069-9.909-0.3340.410.9130.0250.0040.5920.065-5.7560.230.7050.114-15.536
Income Before Tax 7091,3721,296.7581,942.581,002.6151,050.5192,297.1434,193.3881,831.9422,748.4131,029.6112,574.7662,326.649893.489655.227-110.368-127.388-2.299639.75495.55653.364382.11534.25597.50527.509552.524538.50412.13712.461288.023466.476-82.953-48.127189.335290.033
Income Before Tax Ratio 0.3680.50.4320.5690.4590.4390.5340.7030.5860.6560.4040.6350.5960.3760.383-0.133-0.208-0.0020.2780.0750.0520.210.2480.0830.0290.2570.2620.0120.0140.1770.231-0.105-0.070.1290.198
Income Tax Expense 189402350.143576.463287.523304.103591.561,264.586545.289831.356294.158789.721681.815242.048176.751-31.984-37.1811.24181.897-7.28511.449110.378134.16216.258-6.946149.113120.772-8.189-1.60780.1110.353-23.388-19.62962.18973.527
Net Income 519970946.6141,366.118715.0917461,705.5822,928.8021,286.6531,917.057735.4521,785.0451,644.834651.441478.476-78.385-90.206-3.539457.857102.84141.915271.731400.09381.24634.455403.411417.73220.32614.068207.923356.123-59.565-28.499127.146216.506
Net Income Ratio 0.2690.3540.3160.40.3270.3120.3970.4910.4120.4580.2880.440.4210.2740.28-0.095-0.148-0.0030.1990.080.0410.150.1860.0690.0370.1870.2030.020.0160.1270.176-0.075-0.0410.0870.147
EPS 27.25101.8499.39143.4375.0878.37179.07307.5135.09201.2838.6193.71172.768.450.19-8.23-9.47-0.3748.0910.814.4128.53428.612.3842.3587.772.25.8821.83149.5-25.01-11.9713.35100.22
EPS Diluted 27.25101.8499.39143.4375.0878.37179.07307.5135.09201.2838.6193.71172.768.450.19-8.23-9.47-0.3748.0910.814.4128.53428.612.3842.3587.772.25.8821.83149.5-25.01-11.9713.35100.22
EBITDA 6471,3081,414.8421,885.893875.7591,027.6632,374.6734,115.8581,831.9422,748.4131,029.6112,542.4922,248.201881.424655.705-109.869-126.858-1.721640.38796.0553.747382.487534.52697.80627.713552.882538.76512.42712.778288.622467.119-82.516-47.382190.525291.234
EBITDA Ratio 0.3360.4770.4720.5520.4010.430.5520.690.5860.6560.4040.6270.5760.3710.383-0.133-0.208-0.0020.2780.0750.0520.2110.2480.0830.0290.2570.2620.0120.0140.1770.231-0.105-0.0690.130.198